Cd19tm1(cre)Cgn/Cd19+
Tnftm2.1Gkl/Tnftm2.1Gkl
involves: 129P2/OlaHsd * 129S/SvEv * 129S6/SvEvTac * C57BL/6J
|
normal
immune system phenotype |
J:108572
|
Lta/Tnftm1Eug/Lta/Tnftm1Eug
B6.129-Lta/Tnftm1Eug
|
abnormal sleep pattern |
J:103266
|
|
decreased circulating interferon-gamma level |
J:115034
|
|
decreased IgG1 level |
J:115034
|
|
decreased IgG2a level |
J:115034
|
|
decreased IgG3 level |
J:115034
|
|
decreased interferon-gamma secretion |
J:115034
|
|
decreased susceptibility to induced arthritis |
J:115034
|
|
impaired macrophage phagocytosis |
J:115034
|
|
increased IgM level |
J:115034
|
|
increased susceptibility to bacterial infection |
J:115034
|
|
increased susceptibility to bacterial infection induced morbidity/mortality |
J:115034
|
Lta/Tnftm1Eug/Lta/Tnftm1Eug
involves: 129
|
abnormal humoral immune response |
J:31129
|
|
abnormal spleen marginal zone morphology |
J:31129
|
|
abnormal spleen morphology |
J:31129
|
|
absent lymph nodes |
J:31129
|
|
absent Peyer's patches |
J:31129
|
|
decreased IgA level |
J:31129
|
|
decreased susceptibility to induced morbidity/mortality |
J:31129
|
|
decreased T cell number |
J:31129
|
|
increased B cell number |
J:31129
|
|
increased leukocyte cell number |
J:31129
|
|
increased susceptibility to bacterial infection |
J:31129
|
|
increased susceptibility to induced morbidity/mortality |
J:31129
|
|
increased susceptibility to Poxviridae infection |
J:31129
|
|
increased susceptibility to Riboviria infection |
J:31129
|
Lta/Tnftm1Eug/Lta/Tnftm1Eug
involves: 129 * C57BL/6J
|
enlarged liver |
J:112797
|
|
hepatic steatosis |
J:112797
|
|
increased body length |
J:112797
|
|
increased body mass index |
J:112797
|
|
increased body weight |
J:112797
|
|
increased heart weight |
J:112797
|
|
increased liver weight |
J:112797
|
|
increased spleen weight |
J:112797
|
|
increased susceptibility to diet-induced obesity |
J:112797
|
|
long tibia |
J:112797
|
Lta/Tnftm1Eug/Lta/Tnftm1Eug
involves: 129/Sv * C57BL/6
|
decreased susceptibility to experimental autoimmune encephalomyelitis |
J:115225
|
|
decreased susceptibility to parasitic infection |
J:37696
|
|
increased susceptibility to induced morbidity/mortality |
J:61314
|
|
increased susceptibility to injury |
J:61314
|
Lta/Tnftm1Fda/Tnf+
involves: 129S1/Sv * 129X1/SvJ
|
decreased susceptibility to endotoxin shock |
J:39519
|
|
decreased tumor necrosis factor secretion |
J:39519
|
|
increased susceptibility to bacterial infection |
J:39519
|
Lta/Tnftm1Fda/Lta/Tnftm1Fda
involves: 129S1/Sv * 129X1/SvJ
|
decreased susceptibility to endotoxin shock |
J:39519
|
|
decreased tumor necrosis factor secretion |
J:39519
|
|
increased susceptibility to bacterial infection |
J:39519
|
Lta/Tnftm1Jods/Lta/Tnftm1Jods
C57BL/6-Lta/Tnftm1Jods
|
abnormal spleen white pulp morphology |
J:78229
|
|
decreased susceptibility to experimental autoimmune encephalomyelitis |
J:47428
|
Lta/Tnftm1Jods/Lta/Tnftm1Jods
C57BL/6J-Lta/Tnftm1Jods
|
abnormal spleen morphology |
J:43602
|
|
absent lymph nodes |
J:43602
|
|
absent Peyer's patches |
J:43602
|
|
decreased immunoglobulin level |
J:43602
|
|
enlarged spleen |
J:43602
|
|
increased leukocyte cell number |
J:43602
|
Lta/Tnftm1Jods/Lta/Tnftm1Jods
involves: C57BL/6
|
abnormal gamma-delta T cell morphology |
J:169863
|
Ltb/Tnf/Ltatm1Dvk/Ltb/Tnf/Ltatm1Dvk
B6.Cg-Ltb/Tnf/Ltatm1Dvk
|
abnormal class switch recombination |
J:80616
|
|
abnormal spleen morphology |
J:80616
|
|
absent axillary lymph nodes |
J:80616
|
|
absent brachial lymph nodes |
J:80616
|
|
absent inguinal lymph nodes |
J:80616
|
|
absent lymph nodes |
J:80616
|
|
absent mesenteric lymph nodes |
J:80616
|
|
absent Peyer's patches |
J:80616
|
|
absent popliteal lymph nodes |
J:80616
|
|
absent spleen germinal center |
J:80616
|
|
absent spleen marginal zone |
J:80616
|
|
decreased IgG level |
J:80616
|
|
decreased spleen B cell follicle number |
J:80616
|
|
decreased spleen white pulp amount |
J:80616
|
|
increased leukocyte cell number |
J:80616
|
|
increased susceptibility to bacterial infection |
J:80616
|
Ltb/Tnf/Ltatm1Dvk/Ltb/Tnf/Ltatm1Dvk
involves: C57BL/6
|
decreased spleen white pulp amount |
J:109621
|
Ltb/Tnftm1.1Dvk/Ltb/Tnftm1.1Dvk
involves: 129P2/OlaHsd * BALB/cJ * C57BL/6
|
abnormal mesenteric lymph node morphology |
J:58981
|
|
abnormal spleen morphology |
J:58981
|
|
absent axillary lymph nodes |
J:58981
|
|
absent brachial lymph nodes |
J:58981
|
|
absent cervical lymph nodes |
J:58981
|
|
absent follicular dendritic cells |
J:58981
|
|
absent germinal center B cells |
J:58981
|
|
absent inguinal lymph nodes |
J:58981
|
|
absent peripheral lymph nodes |
J:58981
|
|
absent Peyer's patches |
J:58981
|
|
absent popliteal lymph nodes |
J:58981
|
|
absent spleen marginal zone |
J:58981
|
|
intermingled spleen red and white pulp |
J:58981
|
TnfBpsm1/Tnf+
C.Cg-TnfBpsm1
|
aortic aneurysm |
J:226052
|
|
aortic valve inflammation |
J:226052
|
|
cardiac fibrosis |
J:226052
|
|
cardiac valve regurgitation |
J:226052
|
|
cardiovalvulitis |
J:226052
|
|
mitral valve inflammation |
J:226052
|
|
premature death |
J:226052
|
|
thick aortic valve |
J:226052
|
|
thick mitral valve |
J:226052
|
TnfBpsm1/Tnf+
involves: C57BL/6
|
abnormal limb morphology |
J:226052
|
|
abnormal rib joint morphology |
J:226052
|
|
abnormal spine curvature |
J:226052
|
|
abnormal thoracic vertebrae morphology |
J:226052
|
|
aortic aneurysm |
J:226052
|
|
aortic valve inflammation |
J:226052
|
|
decreased grip strength |
J:226052
|
|
hindlimb paralysis |
J:226052
|
|
increased circulating tumor necrosis factor level |
J:226052
|
|
joint dislocation |
J:226052
|
|
kyphosis |
J:226052
|
|
mitral valve inflammation |
J:226052
|
|
normal
mortality/aging |
J:226052
|
|
rheumatoid arthritis |
J:226052
|
TnfBpsm1/TnfBpsm1
involves: C57BL/6
|
abnormal wrist joint morphology |
J:226052
|
|
accelerated temporomandibular joint osteoarthritis |
J:226052
|
|
aortic aneurysm |
J:226052
|
|
aortic valve inflammation |
J:226052
|
|
increased circulating tumor necrosis factor level |
J:226052
|
|
joint dislocation |
J:226052
|
|
limb paralysis |
J:226052
|
|
mitral valve inflammation |
J:226052
|
|
normal
mortality/aging |
J:226052
|
|
rheumatoid arthritis |
J:226052
|
Tnfem4Boui/Tnf+
C57BL/6-Tnfem4Boui
|
arthritis |
J:306876
|
|
cardiovalvulitis |
J:306876
|
|
colitis |
J:306876
|
|
esophageal inflammation |
J:306876
|
|
ileum inflammation |
J:306876
|
|
premature death |
J:306876
|
Tnfem4Boui/Tnfem4Boui
C57BL/6-Tnfem4Boui
|
abnormal embryo morphology |
J:306876
|
|
decreased embryo size |
J:306876
|
|
lethality throughout fetal growth and development, complete penetrance |
J:306876
|
Tnfem5Boui/Tnfem5Boui
C57BL/6-Tnfem5Boui
|
prenatal lethality, complete penetrance |
J:306876
|
TnfM1Btlr/Tnf+
C57BL/6J-TnfM1Btlr
|
decreased follicular dendritic cell number |
J:124642
|
|
normal
immune system phenotype |
J:124642
|
TnfM1Btlr/TnfM1Btlr
C57BL/6J-TnfM1Btlr
|
decreased follicular dendritic cell number |
J:124642
|
|
normal
immune system phenotype |
J:124642
|
|
increased susceptibility to bacterial infection |
J:124642
|
TnfM2Btlr/Tnf+
C57BL/6J-TnfM2Btlr
|
decreased macrophage cytokine production |
J:213047
|
|
decreased tumor necrosis factor secretion |
J:213047
|
TnfR8H/TnfR8H
involves: I/St
|
increased susceptibility to bacterial infection |
J:114302
|
|
increased susceptibility to induced morbidity/mortality |
J:114302
|
Tnftm1.1Sned/Tnftm1.1Sned
Cd19tm1(cre)Cgn/Cd19+
involves: 129 * 129P2/OlaHsd * C57BL/6
|
normal
immune system phenotype |
J:95684
|
Tnftm1.1Sned/Tnftm1.1Sned
Lyz2tm1(cre)Ifo/Lyz2+
involves: 129 * 129P2/OlaHsd * C57BL/6
|
abnormal chemokine secretion |
J:95684
|
|
decreased circulating tumor necrosis factor level |
J:95684
|
|
decreased susceptibility to autoimmune disorder |
J:95684
|
|
decreased susceptibility to endotoxin shock |
J:95684
|
|
hepatic necrosis |
J:95684
|
|
increased susceptibility to bacterial infection |
J:95684
|
|
increased susceptibility to induced morbidity/mortality |
J:95684
|
Tnftm1.1Sned/Tnftm1.1Sned
Tg(Cd4-cre)1Cwi/0
involves: 129 * C57BL/6 * DBA/2
|
decreased circulating tumor necrosis factor level |
J:95684
|
|
decreased susceptibility to autoimmune disorder |
J:95684
|
|
decreased susceptibility to endotoxin shock |
J:95684
|
|
increased susceptibility to bacterial infection |
J:95684
|
|
increased susceptibility to induced morbidity/mortality |
J:95684
|
Tnftm1.2Sned/Tnftm1.2Sned
involves: 129/Sv * C57BL/6
|
absent Peyer's patches |
J:97783
|
|
decreased susceptibility to bacterial infection |
J:97783
|
|
increased leukocyte cell number |
J:97783
|
|
increased susceptibility to parasitic infection |
J:97783
|
Tnftm1Gkl/Tnftm1Gkl
B6;129S-Tnftm1Gkl/J
|
abnormal spermatogenesis |
J:143457
|
|
abnormal spermiation |
J:143457
|
|
abnormal testis physiology |
J:143457
|
|
decreased testes secretion |
J:143457
|
|
decreased testis weight |
J:143457
|
|
oligozoospermia |
J:143457
|
Tnftm1Gkl/Tnftm1Gkl
C.129S-Tnftm1Gkl
|
decreased incidence of tumors by chemical induction |
J:56068
|
Tnftm1Gkl/Tnftm1Gkl
either: B6.129-Tnftm1Gkl or (involves: 129 * C57BL/6)
|
decreased Peyer's patch number |
J:97783
|
|
decreased susceptibility to bacterial infection |
J:97783
|
|
increased leukocyte cell number |
J:97783
|
|
increased lymphocyte cell number |
J:97783
|
|
increased neutrophil cell number |
J:97783
|
|
increased susceptibility to parasitic infection |
J:97783
|
|
small Peyer's patches |
J:97783
|
Tnftm1Gkl/Tnftm1Gkl
involves: 129S/SvEv
|
abnormal chemokine secretion |
J:95684
|
|
decreased circulating tumor necrosis factor level |
J:95684
|
|
decreased susceptibility to autoimmune disorder |
J:95684
|
|
decreased susceptibility to endotoxin shock |
J:95684
|
|
increased susceptibility to bacterial infection |
J:95684
|
Tnftm1Gkl/Tnftm1Gkl
involves: 129S/SvEv * C57BL/6
|
abnormal fat pad morphology |
J:42579
|
|
abnormal glucose homeostasis |
J:42579
|
|
abnormal inflammatory response |
J:114740
|
|
abnormal lipid homeostasis |
J:42579
|
|
abnormal lymph node B cell domain morphology |
J:40970
|
|
abnormal lymphocyte physiology |
J:114740
|
|
abnormal macrophage physiology |
J:114740
|
|
abnormal mesenteric lymph node morphology |
J:114740
|
|
abnormal Peyer's patch follicle morphology |
J:40970
|
|
abnormal Peyer's patch morphology |
J:40970
|
|
abnormal spleen follicular dendritic cell network |
J:42579
|
|
abnormal spleen primary B follicle morphology |
J:47673
|
|
abnormal trabecular bone morphology |
J:135519
|
|
absent follicular dendritic cells |
J:40970
|
|
absent spleen germinal center |
J:47673,
J:114740
|
|
alveolar process atrophy |
J:147935
|
|
decreased body weight |
J:42579
|
|
decreased circulating glucose level |
J:42579
|
|
decreased circulating insulin level |
J:42579
|
|
decreased circulating leptin level |
J:42579
|
|
decreased circulating triglyceride level |
J:42579
|
|
decreased incidence of tumors by chemical induction |
J:56068
|
|
decreased inflammatory response |
J:56068
|
|
decreased keratinocyte proliferation |
J:56068
|
|
decreased percent body fat/body weight |
J:42579
|
|
decreased Peyer's patch number |
J:40970
|
|
decreased susceptibility to experimental autoimmune encephalomyelitis |
J:114740
|
|
decreased susceptibility to type IV hypersensitivity reaction |
J:47673
|
|
normal
immune system phenotype |
J:114740
|
|
increased bone mineral density |
J:135519
|
|
increased osteoblast cell number |
J:135519
|
|
increased susceptibility to bacterial infection |
J:47673,
J:114740
|
Tnftm1Gkl/Tnftm1Gkl
involves: 129S/SvEv * C57BL/6J
|
abnormal metallophilic macrophage morphology |
J:124642
|
|
abnormal Peyer's patch follicle morphology |
J:124642
|
|
abnormal Peyer's patch germinal center morphology |
J:124642
|
|
abnormal Peyer's patch morphology |
J:124642
|
|
abnormal Peyer's patch T cell area morphology |
J:124642
|
|
abnormal spleen follicular dendritic cell network |
J:124642
|
|
abnormal spleen marginal sinus morphology |
J:124642
|
|
abnormal spleen primary B follicle morphology |
J:124642
|
|
absent spleen germinal center |
J:124642
|
|
decreased Peyer's patch number |
J:124642
|
|
increased susceptibility to bacterial infection |
J:124642
|
Tnftm1Gkl/Tnftm2Gkl
involves: 129S/SvEv * C57BL/6
|
increased circulating tumor necrosis factor level |
J:54056
|
|
increased susceptibility to endotoxin shock |
J:54056
|
|
increased tumor necrosis factor secretion |
J:54056
|
|
rheumatoid arthritis |
J:54056
|
Tnftm1Jods/Tnftm1Jods
C57BL/6-Ltatm1Jods
|
abnormal spleen B cell follicle morphology |
J:78229
|
|
decreased susceptibility to experimental autoimmune encephalomyelitis |
J:47428
|
Tnftm1Jods/Tnftm1Jods
C57BL/6-Tnftm1Jods
|
abnormal cytokine level |
J:118417
|
|
decreased susceptibility to experimental autoimmune encephalomyelitis |
J:118417
|
Tnftm1Jods/Tnftm1Jods
involves: C57BL/6
|
abnormal immune system physiology |
J:98591
|
|
abnormal lymph node primary follicle morphology |
J:98591
|
|
abnormal metallophilic macrophage morphology |
J:98591
|
|
abnormal Peyer's patch follicle morphology |
J:43602
|
|
abnormal Peyer's patch morphology |
J:43602,
J:98591
|
|
abnormal spleen marginal sinus morphology |
J:43602
|
|
abnormal spleen primary B follicle morphology |
J:43602,
J:98591
|
|
abnormal spleen white pulp morphology |
J:43602,
J:98591
|
|
absent spleen germinal center |
J:98591
|
|
decreased follicular dendritic cell number |
J:43602
|
|
decreased Peyer's patch number |
J:43602
|
|
decreased susceptibility to endotoxin shock |
J:98591
|
|
decreased susceptibility to experimental autoimmune encephalomyelitis |
J:44545,
J:98591
|
|
increased leukocyte cell number |
J:43602
|
|
increased susceptibility to bacterial infection |
J:98170,
J:115034
|
|
small Peyer's patches |
J:43602
|
Tnftm1Ljo/Tnf+
involves: 129S1/Sv
|
increased susceptibility to bacterial infection |
J:41992
|
|
increased susceptibility to fungal infection |
J:41992
|
Tnftm1Ljo/Tnftm1Ljo
B6.129S1-Tnftm1Ljo
|
abnormal cerebral cortex morphology |
J:120489
|
|
abnormal long-term spatial reference memory |
J:120489
|
|
abnormal lung morphology |
J:127028
|
|
abnormal motor coordination/balance |
J:120489
|
|
decreased apoptosis |
J:127028
|
|
impaired coordination |
J:120489
|
|
lung inflammation |
J:127028
|
Tnftm1Ljo/Tnftm1Ljo
either: B6.129-Tnftm1Ljo or (involves: 129 * C57BL/6)
|
abnormal Peyer's patch follicle morphology |
J:97783
|
|
abnormal Peyer's patch germinal center morphology |
J:97783
|
|
abnormal Peyer's patch T cell area morphology |
J:97783
|
|
absent follicular dendritic cells |
J:97783
|
|
decreased Peyer's patch number |
J:97783
|
|
decreased susceptibility to bacterial infection |
J:97783
|
|
increased leukocyte cell number |
J:97783
|
|
increased lymphocyte cell number |
J:97783
|
|
increased neutrophil cell number |
J:97783
|
|
increased susceptibility to parasitic infection |
J:97783
|
|
small Peyer's patches |
J:97783
|
Tnftm1Ljo/Tnftm1Ljo
involves: 129S1/Sv
|
abnormal chemokine secretion |
J:95684
|
|
abnormal cytokine secretion |
J:41992
|
|
abnormal follicular dendritic cell physiology |
J:41992
|
|
abnormal susceptibility to infection |
J:41992
|
|
absent spleen germinal center |
J:41992,
J:80616
|
|
decreased circulating tumor necrosis factor level |
J:95684
|
|
decreased IgG level |
J:41992
|
|
decreased spleen B cell follicle number |
J:95684
|
|
decreased spleen white pulp amount |
J:80616
|
|
decreased susceptibility to autoimmune disorder |
J:95684
|
|
decreased susceptibility to endotoxin shock |
J:41992,
J:95684
|
|
increased susceptibility to bacterial infection |
J:41992,
J:80616,
J:95684
|
|
increased susceptibility to fungal infection |
J:41992
|
Tnftm1Ljo/Tnftm1Ljo
involves: 129S1/Sv * C57BL/6
|
abnormal lymph node cell ratio |
J:127028
|
|
abnormal neutrophil physiology |
J:127028
|
|
decreased immunoglobulin level |
J:127028
|
|
increased interferon-gamma secretion |
J:127028
|
|
increased neutrophil cell number |
J:127028
|
|
increased susceptibility to parasitic infection |
J:127028
|
|
lymph node hypoplasia |
J:127028
|
|
skin inflammation |
J:127028
|
|
skin lesions |
J:127028
|
Tnftm1Ljo/Tnftm1Ljo
involves: 129S1/Sv * C57BL/6J
|
normal
liver/biliary system phenotype |
J:112797
|
Tnftm1Sek/Tnftm1Sek
B6.Cg-Tnftm1Sek
|
abnormal cytokine secretion |
J:44841
|
|
abnormal macrophage physiology |
J:44841
|
|
abnormal mesenteric lymph node morphology |
J:44841
|
|
abnormal Peyer's patch germinal center morphology |
J:44841
|
|
absent lymph node germinal center |
J:44841
|
|
absent spleen germinal center |
J:44841
|
|
decreased circulating interferon-gamma level |
J:44841
|
|
decreased circulating interleukin-1 alpha level |
J:44841
|
|
decreased circulating interleukin-1 beta level |
J:44841
|
|
decreased circulating interleukin-6 level |
J:44841
|
|
decreased coping response |
J:102967
|
|
decreased locomotor activity |
J:102967
|
|
decreased susceptibility to endotoxin shock |
J:44841
|
|
decreased vertical activity |
J:102967
|
|
normal
immune system phenotype |
J:44841
|
|
increased anxiety-related response |
J:102967
|
|
increased grooming behavior |
J:102967
|
|
increased serotonin level |
J:102967
|
Tnftm1Sek/Tnftm1Sek
involves: C57BL/6 * CBA
|
abnormal female reproductive system physiology |
J:59892
|
|
abnormal liver physiology |
J:120559
|
|
abnormal vagina weight |
J:114219
|
|
prolonged estrus |
J:114219
|
Tnftm2.1Gkl/Tnf+
Lyz2tm1(cre)Ifo/Lyz2+
involves: 129P2/OlaHsd * 129S/SvEv * 129S6/SvEvTac * C57BL/6J
|
weight loss |
J:108572
|
Tnftm2.1Gkl/Tnftm2.1Gkl
Lyz2tm1(cre)Ifo/Lyz2+
involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J
|
weight loss |
J:108572
|
Tnftm2.1Gkl/Tnftm2.1Gkl
Tg(Fabp1-cre)1Jig/0
involves: 129S/SvEv * FVB/N
|
abnormal intestinal mucosa morphology |
J:204557
|
|
abnormal small intestinal villus morphology |
J:204557
|
|
decreased small intestinal villus number |
J:204557
|
|
ileum inflammation |
J:204557
|
|
increased circulating tumor necrosis factor level |
J:204557
|
|
large intestinal inflammation |
J:204557
|
|
small intestinal inflammation |
J:204557
|
Tnftm2.1Gkl/Tnftm2.1Gkl
Tg(Lck-cre)I57Jxm/0
involves: 129S/SvEv * ICR
|
small intestinal inflammation |
J:108572
|
Tnftm2Gkl/Tnf+
B6.129S-Tnftm2Gkl/Jarn
|
abnormal CD4-positive, alpha-beta T cell physiology |
J:145626
|
|
abnormal CD8-positive, alpha beta T cell morphology |
J:131978
|
|
ileum inflammation |
J:131978,
J:145626
|
|
increased CD4-positive, alpha-beta memory T cell number |
J:145626
|
|
increased CD4-positive, alpha-beta T cell number |
J:145626
|
|
increased interferon-gamma secretion |
J:131978
|
|
increased interleukin-2 secretion |
J:145626
|
|
increased tumor necrosis factor secretion |
J:145626
|
Tnftm2Gkl/Tnf+
involves: 129S/SvEv * C57BL/6
|
abnormal alpha-beta intraepithelial T cell morphology |
J:136667
|
|
abnormal CD4-positive, alpha-beta T cell physiology |
J:136667
|
|
abnormal CD8-positive, alpha beta T cell morphology |
J:136667
|
|
abnormal circulating chemokine level |
J:204922
|
|
abnormal circulating leptin level |
J:204922
|
|
abnormal food intake |
J:204922
|
|
abnormal glucose homeostasis |
J:204922
|
|
abnormal intestine physiology |
J:204922
|
|
abnormal T cell physiology |
J:136667
|
|
abnormal T cell subpopulation ratio |
J:136667
|
|
abnormal T-helper 17 cell physiology |
J:204922
|
|
alopecia |
J:92307
|
|
arthritis |
J:92307,
J:136667
|
|
decreased inflammatory response |
J:204922
|
|
decreased susceptibility to diet-induced obesity |
J:204922
|
|
ileum inflammation |
J:204922
|
|
increased circulating tumor necrosis factor level |
J:54056,
J:204922
|
|
increased dendritic cell number |
J:204922
|
|
intestinal inflammation |
J:136667
|
|
rheumatoid arthritis |
J:54056
|
|
small intestinal inflammation |
J:54056,
J:92307,
J:204922
|
|
steatorrhea |
J:204922
|
Tnftm2Gkl/Tnf+
involves: 129S/SvEv * C57BL/6 * CBA
|
arthritis |
J:131930
|
Tnftm2Gkl/Tnf+
involves: 129S/SvEv * C57BL/6 * SPRET/Ei
|
alopecia |
J:92307
|
|
arthritis |
J:92307
|
|
small intestinal inflammation |
J:92307
|
Tnftm2Gkl/Tnf+
involves: 129S/SvEv * C57BL/6J
|
abnormal aorta bulb morphology |
J:264147
|
|
abnormal aortic valve flow |
J:264147
|
|
abnormal aortic valve morphology |
J:264147
|
|
abnormal cytotoxic T cell physiology |
J:108572
|
|
abnormal joint morphology |
J:264147
|
|
abnormal myelopoiesis |
J:108572
|
|
abnormal response to transplant |
J:108572
|
|
aortic valve stenosis |
J:264147
|
|
cardiac fibrosis |
J:264147
|
|
decreased cardiac output |
J:264147
|
|
decreased heart rate |
J:264147
|
|
decreased ventricle muscle contractility |
J:264147
|
|
enhanced wound healing |
J:264147
|
|
enlarged spleen |
J:108572
|
|
increased apoptosis |
J:108572
|
|
increased CD8-positive, alpha-beta T cell number |
J:108572
|
|
increased cell migration |
J:264147
|
|
increased cell proliferation |
J:264147
|
|
increased circulating tumor necrosis factor level |
J:264147
|
|
increased fibroblast cell migration |
J:264147
|
|
increased fibroblast proliferation |
J:264147
|
|
increased tumor necrosis factor secretion |
J:264147
|
|
prolonged QT interval |
J:264147
|
|
small intestinal inflammation |
J:108572
|
|
thick aortic valve cusps |
J:264147
|
Tnftm2Gkl/Tnftm2Gkl
involves: 129S/SvEv * C57BL/6
|
cardiovalvulitis |
J:226052
|
|
decreased body weight |
J:54056
|
|
increased circulating tumor necrosis factor level |
J:54056
|
|
premature death |
J:54056
|
|
rheumatoid arthritis |
J:54056
|
|
small intestinal inflammation |
J:54056
|
|
thymus hypoplasia |
J:54056
|
Tnftm2Jods/Tnftm2Jods
C57BL/6-Tnftm2Jods
|
abnormal immune system physiology |
J:98591
|
|
abnormal lymph node primary follicle morphology |
J:98591
|
|
abnormal metallophilic macrophage morphology |
J:98591
|
|
abnormal Peyer's patch follicle morphology |
J:98591
|
|
abnormal spleen follicular dendritic cell network |
J:98591
|
|
abnormal spleen primary B follicle morphology |
J:98591
|
|
abnormal spleen white pulp morphology |
J:98591
|
|
decreased spleen germinal center number |
J:98591
|
|
decreased spleen germinal center size |
J:98591
|
|
decreased susceptibility to endotoxin shock |
J:98591
|
|
decreased susceptibility to experimental autoimmune encephalomyelitis |
J:98591
|
Tnftm2Jods/Tnftm2Jods
involves: C57BL/6
|
abnormal lymph node cell ratio |
J:127028
|
|
decreased immunoglobulin level |
J:127028
|
|
normal
immune system phenotype |
J:127028
|
|
increased susceptibility to bacterial infection |
J:98170
|
Tnftm2Jods/Tnftm2Jods
involves: C57BL/6 * C57BL/6J
|
decreased liver free fatty acids level |
J:112797
|
Tnftm3Gkl/Tnftm3Gkl
involves: 129S/SvEv * C57BL/6
|
abnormal lymph node B cell domain morphology |
J:114740
|
|
abnormal lymphocyte physiology |
J:114740
|
|
abnormal mesenteric lymph node morphology |
J:114740
|
|
abnormal spleen primary B follicle morphology |
J:114740
|
|
absent follicular dendritic cells |
J:114740
|
|
absent spleen germinal center |
J:114740
|
|
autoimmune response |
J:114740
|
|
decreased circulating tumor necrosis factor level |
J:114740
|
|
decreased IgG1 level |
J:114740
|
|
decreased susceptibility to bacterial infection |
J:114740
|
|
decreased susceptibility to endotoxin shock |
J:114740
|
|
decreased susceptibility to experimental autoimmune encephalomyelitis |
J:114740
|
|
decreased tumor necrosis factor secretion |
J:114740
|
Excel File
Analysis Tools